Community pharmacies play a pivotal role in expanding access to HIV prevention and treatment. This continuing education program explores practical strategies for pharmacists to engage in HIV screening, counseling, and linkage to care; optimize antiretroviral therapy management; and promote vaccination and preventive health among people living with HIV. Participants will gain actionable insights to implement scalable HIV services within the community pharmacy setting, supporting both individual patient outcomes and public health goals.

Course Details

Date: Thursday, November 13, 2025
Time: 10 a.m. to 11 a.m. via webinar
(Webinar will also be available on demand following the event if your schedule does not allow for live viewing.)

Presented by:
Kevin Aloysius, PharmD, AAHIVP • Director of Pharmacy Operations, Legacy Community Health Services

CE Credit:
This lesson is a knowledge-based CE activity and is targeted to pharmacists and technicians. This program has been approved for 1.0 contact hours of continuing education credit (0.1 CEU).

• Pharmacists: 0154-0000-25-038-L02-P
• Technicians: 0154-0000-25-038-L02-T

Pricing:
Members: FREE (Log in to your TPA account to receive free CE.)
Non-Members: $25

Learning Objectives:

At the completion of this activity, pharmacists and technicians will be able to:

1. Identify opportunities for community pharmacies to engage in HIV prevention through screening, counseling, and access to HIV self-testing, PrEP, and PEP services.
2. Describe key considerations in dispensing antiretroviral therapies, including recognizing common drug–drug interactions, managing side effects, and identifying opportunities for preventive care such as lipid management and vaccination.
3. Recommend appropriate vaccines and timing for people living with HIV, based on CD4 count, immune status, and current CDC/ACIP guidelines.
4. Develop a plan for implementing scalable HIV care initiatives within community pharmacy settings, ranging from basic awareness and testing to collaborative practice models and clinical research participation.